| A simple equation for description of solute release II. Fickian and anomalous release from swellable devices | 1987/06/01 | English | 3,033 |
| A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs | 1987/06/01 | English | 2,818 |
| Doxil® — The first FDA-approved nano-drug: Lessons learned | 2012/06/01 | English | 2,784 |
| DLS and zeta potential – What they are and what they are not? | 2016/08/01 | English | 2,287 |
| PLGA-based nanoparticles: An overview of biomedical applications | 2012/07/01 | English | 2,267 |
| To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery | 2010/12/01 | English | 1,798 |
| Recent advances on chitosan-based micro- and nanoparticles in drug delivery | 2004/11/01 | English | 1,671 |
| A review of stimuli-responsive nanocarriers for drug and gene delivery | 2008/03/01 | English | 1,658 |
| Toxicity of cationic lipids and cationic polymers in gene delivery | 2006/08/01 | English | 1,603 |
| Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles | 2008/12/01 | English | 1,570 |
| Endocytosis of nanomedicines | 2010/08/01 | English | 1,492 |
| Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan — a review | 2006/08/01 | English | 1,289 |
| Targeted drug delivery to tumors: Myths, reality and possibility | 2011/08/01 | English | 1,244 |
| Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications | 2015/02/01 | English | 1,238 |
| Exosomes as drug delivery vehicles for Parkinson's disease therapy | 2015/06/01 | English | 1,227 |
| “Nanoantibiotics”: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era | 2011/12/01 | English | 1,197 |
| Endosomal escape pathways for delivery of biologicals | 2011/05/01 | English | 1,119 |
| Block copolymer micelles: preparation, characterization and application in drug delivery | 2005/12/01 | English | 1,086 |
| Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery | 2011/05/01 | English | 1,064 |
| Albumin-based nanoparticles as potential controlled release drug delivery systems | 2012/01/01 | English | 976 |
| Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers | 2008/09/01 | English | 942 |
| Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress | 2012/07/01 | English | 938 |
| Particle shape: A new design parameter for micro- and nanoscale drug delivery carriers | 2007/08/01 | English | 915 |
| Graphene-based nanomaterials for drug delivery and tissue engineering | 2014/01/01 | English | 882 |
| To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine? | 2016/12/01 | English | 863 |
| Electrospinning of polymeric nanofibers for drug delivery applications | 2014/07/01 | English | 852 |
| Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases | 2016/08/01 | English | 851 |
| PEG-modified gold nanorods with a stealth character for in vivo applications | 2006/09/01 | English | 834 |
| Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach | 2006/11/01 | English | 793 |
| Nanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination | 2016/10/01 | English | 791 |